Citius PharmaceuticalsCTXR
那斯達克 · USD
0.58
+0.01
(+1.47%)
收盤 09/26 03:02 (UTC+8)
09/26 03:02 (UTC+8)
Citius PharmaceuticalsCTXR
0.58
+0.01
(+1.47%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- 0.04
- 0.02
- 0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -57.73
- -10.38
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 1,494 | 1,667 | 3,944 | - | - | - | - | - | - | - |
營業成本 | 492 | 329 | 789 | - | - | - | - | - | - | - |
營業毛利 | 1,002 | 1,338 | 3,155 | - | - | - | - | - | - | - |
營業費用 | 12,734 | 33,533 | 12,174 | 8,438 | 8,788 | 11,261 | - | 11,051 | - | - |
研發費用 | 1,054 | 1,634 | 1,600 | 1,642 | 1,621 | 3,767 | 2,127 | 2,915 | 2,764 | 3,606 |
推銷及管理費用 | 9,960 | 30,179 | 10,001 | 6,796 | 7,167 | 7,494 | 7,913 | 8,136 | 7,870 | 7,364 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 1,720 | 1,720 | 573 | - | - | - | - | - | - | - |
營業利益 | -11,732 | -32,195 | -9,019 | -8,437 | -8,788 | -11,261 | -10,040 | -11,050 | -10,634 | -10,970 |
其他收入及費用 | -63 | 3,887 | 45 | 53 | 21 | 13 | 23 | 117 | 205 | 2,570 |
利息費用 | 232 | 33 | 156 | 96 | 172 | - | - | - | - | - |
稅前純益 | -12,027 | -28,341 | -9,130 | -8,479 | -8,940 | -11,247 | -10,017 | -10,933 | -10,429 | -8,400 |
所得稅 | -107 | -231 | 264 | 264 | 264 | 264 | 264 | 144 | 144 | 144 |
稅後純益 | -8,863 | -21,231 | -8,221 | -7,959 | -8,790 | -10,917 | -9,768 | -10,790 | -10,573 | -8,544 |
基本每股稅後盈餘(元) | -0.34 | -0.95 | -0.38 | -0.01 | -0.80 | -1.27 | -1.30 | -0.07 | -0.06 | -0.05 |
稀釋每股稅後盈餘(元) | -0.30 | -0.96 | -0.38 | -0.11 | -0.69 | -1.28 | -1.30 | -0.06 | -0.06 | -0.05 |
基本平均股數(千股) | 26169.00 | 22376.00 | 21495.00 | 17181.00 | 11006.00 | 8581.00 | 7492.00 | 180849.00 | 173856.00 | 159072.00 |
稀釋平均股數(千股) | 26169.00 | 22376.00 | 21495.00 | 17181.00 | 11006.00 | 8581.00 | 7492.00 | 180849.00 | 173856.00 | 159072.00 |
還原基本每股稅後盈餘(元) | -0.34 | -0.95 | -0.38 | -0.01 | -0.80 | -1.27 | -1.30 | -1.68 | -1.57 | -1.34 |
還原稀釋每股稅後盈餘(元) | -0.30 | -0.96 | -0.38 | -0.11 | -0.69 | -1.28 | -1.30 | -1.60 | -1.58 | -1.34 |
還原基本平均股數(千股) | 26,169 | 22,376 | 21,495 | 17,181 | 11,006 | 8,581 | 7,492 | 7,233 | 6,954 | 6,362 |
還原稀釋平均股數(千股) | 26,169 | 22,376 | 21,495 | 17,181 | 11,006 | 8,581 | 7,492 | 7,233 | 6,954 | 6,362 |
EBITDA(千元) | -6,797 | -19,668 | -7,244 | -7,537 | -8,313 | -10,597 | -9,449 | -10,592 | -10,376 | -8,348 |